Testing effectiveness (Phase 2)Study completedNCT01798446
What this trial is testing
A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus
Who this might be right for
Renal Cell CarcinomaNonclear CellTemsirolimus Resistance
Seoul National University Hospital 41